Literature DB >> 10531211

Temporal sequence of pulmonary and systemic inflammatory responses to graded polymicrobial peritonitis in mice.

C Stamme1, D S Bundschuh, T Hartung, U Gebert, L Wollin, R Nüsing, A Wendel, S Uhlig.   

Abstract

The lungs are the remote organ most commonly affected in human peritonitis. The major goals of this study were to define the dose- and time-dependent relationship between graded septic peritonitis and systemic and pulmonary inflammatory responses in mice. BALB/c mice were treated with intraperitoneal polymicrobial inoculi and sacrificed at 3, 12, and 24 h. The treatment protocol resulted in distinct groups of animals with respect to mortality rate, kinetics, and concentrations of a broad spectrum of pro- and anti-inflammatory endogenous mediators, intrapulmonary bacterial accumulation, and static lung compliance. In sublethally infected mice, pulmonary bacterial proliferation was controlled. Levels of monocyte chemoattractant protein-1 (MCP-1), interleukin-10, interleukin-6, granulocyte colony-stimulating factor (G-CSF), and tumor necrosis factor (TNF) in plasma were elevated 3 h after infection exclusively. At 3 h, MCP-1, gamma interferon, and TNF were detected in extracts of pulmonary tissue or in bronchoalveolar lavage (BAL) fluid. Static lung compliance (C(st)) was transiently decreased at 12 h. In contrast, in lethally infected mice pulmonary bacterial proliferation was not contained. Concentrations of MCP-1, G-CSF, and TNF in plasma were maximal at 24 h, as were pulmonary MCP-1 levels. Lung myeloperoxidase activity was increased at 3, 12, and 24 h. C(st) was reduced after 3 h and did not reach control values at 24 h. Pulmonary cyclooxygenase-2 mRNA and eicosanoids in BAL fluid and plasma were elevated at 3 and 24 h. This study shows that polymicrobial peritonitis in mice leads to dose-dependent systemic and pulmonary inflammation accompanied by a decrease in lung compliance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531211      PMCID: PMC96937     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat.

Authors:  S F Liu; R Newton; T W Evans; P J Barnes
Journal:  Clin Sci (Lond)       Date:  1996-04       Impact factor: 6.124

2.  Balance of inflammatory cytokines related to severity and mortality of murine sepsis.

Authors:  K R Walley; N W Lukacs; T J Standiford; R M Strieter; S L Kunkel
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Endogenous IL-10 protects mice from death during septic peritonitis.

Authors:  T van der Poll; A Marchant; W A Buurman; L Berman; C V Keogh; D D Lazarus; L Nguyen; M Goldman; L L Moldawer; S F Lowry
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

4.  Outcome of patients with abdominal sepsis treated in an intensive care unit.

Authors:  G J McLauchlan; I D Anderson; I S Grant; K C Fearon
Journal:  Br J Surg       Date:  1995-04       Impact factor: 6.939

5.  Control of fecal peritoneal infection in mice by colony-stimulating factors.

Authors:  J Barsig; D S Bundschuh; T Hartung; A Bauhofer; A Sauer; A Wendel
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

6.  Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.

Authors:  S Uhlig; R Nüsing; A von Bethmann; R L Featherstone; T Klein; F Brasch; K M Müller; V Ullrich; A Wendel
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

7.  Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.

Authors:  P Villa; G Sartor; M Angelini; M Sironi; M Conni; P Gnocchi; A M Isetta; G Grau; W Buurman; L J van Tits
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

8.  Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture.

Authors:  K M McMasters; J C Peyton; D J Hadjiminas; W G Cheadle
Journal:  Cytokine       Date:  1994-09       Impact factor: 3.861

Review 9.  The abdomen as source of sepsis in critically ill patients.

Authors:  R C Merrell
Journal:  Crit Care Clin       Date:  1995-04       Impact factor: 3.598

10.  Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis.

Authors:  D J Hadjiminas; K M McMasters; J C Peyton; M D Cook; W G Cheadle
Journal:  Shock       Date:  1994-11       Impact factor: 3.454

View more
  11 in total

Review 1.  Translational approaches to treatment-induced symptoms in cancer patients.

Authors:  Robert Dantzer; Mary W Meagher; Charles S Cleeland
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

Review 2.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Neutrophilic infiltration in lungs of mice with peritonitis in acid or basic medium.

Authors:  Bruno F Muniz; Gabriel M Netto; Moacir Jr Ferreira; Luana O Prata; Cláudio C Mayrink; Yuri L Guimarães; Marcelo V Caliari; Ivana Duval-Araujo
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries.

Authors:  Dan Secor; Fuyan Li; Christopher G Ellis; Michael D Sharpe; Peter L Gross; John X Wilson; Karel Tyml
Journal:  Intensive Care Med       Date:  2010-08-06       Impact factor: 17.440

5.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Knockout of the Bcmo1 gene results in an inflammatory response in female lung, which is suppressed by dietary beta-carotene.

Authors:  Yvonne G J van Helden; Sandra G Heil; Frederik J van Schooten; Evelien Kramer; Susanne Hessel; Jaume Amengual; Joan Ribot; Katja Teerds; Adrian Wyss; Georg Lietz; M Luisa Bonet; Johannes von Lintig; Roger W L Godschalk; Jaap Keijer
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

7.  Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism.

Authors:  Karel Tyml; Fuyan Li; John X Wilson
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

8.  Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1.

Authors:  Xiao-hui Li; Xia Gong; Li Zhang; Rong Jiang; Hong-zhong Li; Meng-jiao Wu; Jing-yuan Wan
Journal:  Mediators Inflamm       Date:  2013-01-30       Impact factor: 4.711

9.  Inhalative IL-10 attenuates pulmonary inflammation following hemorrhagic shock without major alterations of the systemic inflammatory response.

Authors:  Philipp Kobbe; Philipp Lichte; Helen Schreiber; Lucy Kathleen Reiss; Stefan Uhlig; Hans-Christoph Pape; Roman Pfeifer
Journal:  Mediators Inflamm       Date:  2011-10-20       Impact factor: 4.711

10.  Difficulties in modelling ARDS (2017 Grover Conference Series).

Authors:  Stefan Uhlig; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2018-03-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.